DocGo Inc. Common Stock earnings per share and revenue
On Mar 16, 2026, DCGO reported earnings of -1.37 USD per share (EPS) for Q4 25, missing the estimate of -0.13 USD, resulting in a -920.10% surprise. Revenue reached 74.94 million, compared to an expected 71.76 million, with a 4.42% difference. The market reacted with a -3.90% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 8 analysts forecast an EPS of -0.10 USD, with revenue projected to reach 73.87 million USD, implying an decrease of -92.70% EPS, and decrease of -1.42% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
SBC Medical Group Holdings Incorporated Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
$0.12
Actual
$0.14
Surprise
+15.51%
OSR Holdings, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.16
Surprise
-56.86%
Synergy CHC Corp. Common Stock
Report Date
Apr 01, 2026 For Q4 25
Estimate
$0.01
Actual
-$0.72
Surprise
-7158.82%
Co-Diagnostics, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$3.67
Actual
-$3.64
Surprise
+0.87%
FAQ
What were DocGo Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, DocGo Inc. Common Stock reported EPS of -$1.37, missing estimates by -920.1%, and revenue of $74.94M, 4.42% above expectations.
How did the market react to DocGo Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -3.9%, changed from $0.72 before the earnings release to $0.69 the day after.
When is DocGo Inc. Common Stock expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for DocGo Inc. Common Stock's next earnings report?
Based on 8
analysts, DocGo Inc. Common Stock is expected to report EPS of -$0.10 and revenue of $73.87M for Q1 2026.